1OE

2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid

Find entries where: 1OE

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid
Identifiers	2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid
Formula	C₂₀ H₁₄ Cl N₃ O₃ S
Molecular Weight	411.861
Type	NON-POLYMER
Isomeric SMILES	c1ccc2c(c1)cc(n2CC(=O)O)C(=O)Nc3nc(cs3)c4ccccc4Cl
InChI	InChI=1S/C20H14ClN3O3S/c21-14-7-3-2-6-13(14)15-11-28-20(22-15)23-19(27)17-9-12-5-1-4-8-16(12)24(17)10-18(25)26/h1-9,11H,10H2,(H,25,26)(H,22,23,27)
InChIKey	ILNRQFBVVQUOLP-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	42
Chiral Atom Count	0
Bond Count	45
Aromatic Bond Count	21

Drug Info: DrugBank

DrugBank ID	DB04867
Name	Lintitript
Groups	investigational
Description	Lintitript is a new, highly specific and potent CCK-A receptor antagonist.
Synonyms	Lintitript
Indication	For the treatment of pancreatic cancer and appetite disorders.
Categories	Heterocyclic Compounds, Fused-Ring Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Indoles Sulfur Compounds
CAS number	136381-85-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Cholecystokinin receptor type A	MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSL...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682